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Oxidative tea polyphenols (OTPs) is the oxidative polymerization product of
epigallocatechin-3-O-gallate (EGCG) forms during the process of Pu-er tea
fermentation, and possesses absorption property, which may absorbs on drugs
thus impact the drug bioavailability when taking medicines with Pu-er tea. Here we
demonstrated that OTP inhibited the absorption of atenolol in the intestine, which
was determined by testing atenolol levels of plasma via high performance liquid
chromatography (HPLC). After administration of atenolol (50 mg/kg), atenolol was
absorbed (Tmax: 1.867 h) with the half-life (t1/2) of 6.663 h in control group; Compared
with atenolol group, AUC0 t (h*ng/ml), AUC0 (h∗ng/ml), and Cmax of OTP− −∞ +atenolol
group (OTP 500 mg/kg + atenolol 50 mg/kg) reduced 38.7, 27, and 51%, respectively,
the atenolol concentration of plasma was reduced by OTP approximately 43, 49, and
55.5% at 30 min, 1 and 2 h, respectively, (P < 0.01). Furthermore, the level of atenolol in
feces was higher in the OTP+atenolol group, indicating that the absorption of atenolol
in rats was inhibited by OTP. Isothermal titration calorimetry assay identified that EGCG
can bind to atenolol and the in vitro results showed that OTP absorbed on atenolol and
formed precipitate in acid condition, demonstrating a significant positive relationship
between atenolol levels and OTP dosage. Taken together, these results suggested that
consuming Pu-er tea with atenolol might inhibit atenolol absorption and possible other
drugs.
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INTRODUCTION
One of the main drug delivery methods is oral administration, and proper absorption is necessary
for oral medications to function. The low bioavailability of drugs can be attributed to factors
including physiological factors (such as the digestive system and circulatory system) and physical
and chemical factors (the solubility of a drug, fat-solubility, dissolution rate, and stability) (Kataoka
et al., 2011). The absorption of a single component is often straightforward, but multicomponent
drug absorption is inhibited or promoted by interactions. For example, decanoic acid sodium can
promote the absorption of berberine in the small intestine (Lv et al., 2010), but administration of
oral flavonoids with some medications may result in increased toxicity or a decreased therapeutic
effect due to drug interactions (Tang and Stearns, 2001). Further examination of oral drug
absorption to improve drug efficacy and to reduce adverse effects is a priority in clinical pharmacy
research.
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Polyphenols are secondary metabolites of plants belonging
to a family of natural organic compounds widely contained in
common plant-based foods including vegetables, fruits, cereals,
and wine (Spencer et al., 2008). The molecular structure of
polyphenols consists of multiple phenolic hydroxyl groups
that terminate the propagation of free radical damage by
providing active hydrogen to scavenge free radicals, inhibiting
lipid peroxidation, inducing complex formation of oxidized
transition metal ions, and activating intracellular antioxidant
defense systems to reduce the risk of a number of diseases
including cardiovascular disease and cancer (Yang et al., 2004;
Pandey and Rizvi, 2009; David et al., 2010; Sandhya et al.,
2013). As annexing agents widely used in food production,
polyphenols usually impact the absorption and metabolism of
starch, protein and fat in food. Consumption of polyphenols
with certain medications can lead to unexpected interactions.
Apple juice could reduce the absorption of a drug but citrus juice
could increase the bioavailability of the drug (Jeon et al., 2013).
Another type of material containing high levels of polyphenols
is tea. Some reports suggest that oral absorption and tissue
distribution of metformin are increased after long term use
of tea polyphenols, while the absorption and distribution of
atenolol were not affected (Hussain and Jaccob, 2013). Research
concerning the effects of polyphenols on the absorption of drugs
is still in progress.
Tea was considered to reduce the drug effects in ancient
Chinese saying, oxidative tea polyphenols (OTPs) is the oxidative
polymerization product of EGCG that forms during the process
of Pu-er tea fermentation. and possesses strong absorption
property to combine with caffeine in Pu-er tea to form a complex,
and caffeine can be precipitated under acidic conditions provide a
theoretical basis for the phenomenon of the mitigation insomnia
effects of fermented Pu-er tea in comparison with other kinds
of tea or coffee (Song et al., 2013; Huang et al., 2014). Based
on the adsorption property, whether or not OTP affect the
absorption of drug when taking medicines with consuming
Pu-er tea.
Atenolol is one of the most widely used clinical drugs all
over the world, and atenolol is rapidly but incompletely absorbed
from the GI tract and demonstrates only approximately 40–
50% bioavailability after oral dosing. Approximately 5–15% of
atenolol is bound to plasma proteins (Fitzgerald et al., 1978;
Scott et al., 1988), and it is often used as pattern drug in drug
absorption tests. With atenolol, we investigated the influence of
OTP on some drug absorption. The present study was designed
to evaluate the effect of OTP on the absorption of a single dose of
orally administered atenolol in rats.
MATERIALS AND METHODS
Chemicals and Reagents
Oxidative tea polyphenols was prepared in laboratory as
described (Huang et al., 2014): EGCG (the purity is more than
98%) aqueous solution was oxidized with atmosphere oxygen
at 37◦C under alkaline conditions until the A230 nm/A520 nm
(determined by spectrophotometer, HITACHI, U-2910, the
optical path length is 1.0 cm, sample concentration is
500 mg L−1) equaled 1.40 (the value of the initial tea
polyphenols sample is 10.90). Then, the solution was dried by
lyophilization.
Atenolol was purchased from Micxy Chemical Co., Ltd
(Chengdu, China), EGCG (purity >98%) was purchased from
Chengdu Biopurify Phytochemicals Ltd (Chengdu, China).
Heparin sodium salt was purchased from Beijing Solarbio Science
& Technology Co., Ltd. (Beijing, China). Trichloroacetic acid,
NaOH, and KH2PO4 were purchased from Aladdin (Shanghai,
China). Perchloric acid and Hydrochloric acid were purchased
from Sigma–Aldrich (Shanghai, China). HPLC-grade methanol
and acetonitrile purchased from Tedia Co. Inc. Deionized
water was prepared using a purifier (FST-UV-20, Shanghai
Fushite instrument equipment Co. Ltd. Shanghai, China). Blank
plasma was obtained from Kunming Blood Center (Kunming,
China).
Precipitation of Plasma Protein
Pretreatment of the sample is important for quantitative analysis.
A mass of protein is present in plasma and may impact test
results. Choosing the appropriate precipitating agent for removal
of plasma proteins and test results is crucial. We chose four
different types of commonly used protein precipitant mixes
with blank plasma at a suitable proportion to eliminate 98%
of the protein in plasma: 6% perchloric acid: blank plasma
(1:1); 10% trichloroacetic acid: blank plasma (1:1); methanol:
blank plasma (3:1); acetonitrile: blank plasma (3:1). After vortex
mixing for 30 s, the mixture was centrifuged (CT15RE, Hitachi
Koki Co.Ltd, Japan) at approximately 3000 g for 15 min.
The supernatant solution was transferred into a disposable
1.5 ml microcentrifuge tube. Next, 20 µl of the final solution
was injected into the HPLC system after filtration through a
0.45 µm filter unit (MS R© Nylon Syringe Filter and MCE Syinge
Filter were purchased from Membrane Solutions, Shanghai,
China).
Isothermal Titration Calorimetry Assay
Isothermal titration calorimetry (ITC) assay was performed on
a MicroCal PEAQ-ITC colorimeter (MicroCal, Northampton,
MA, USA) to investigate the binding of EGCG to atenolol.
Titration calorimetry was performed at 25◦C in the assay buffer
(PBS, pH = 6.5). Briefly, the sample and syringe cell were
filled with atenolol (1.1 mM) and EGCG (13 mM), respectively,
which were degassed prior to use. The titrations were conducted
using an initial injection of 0.4 µL followed by 18 identical
injections of 2 µL with duration of 4 s, and with a 150 s
delay between each injection. Curve fitting was performed based
on a one-site binding model to determine the equilibrium
dissociation constants (KD) using the MicroCal PEAQ-ITC
Analysis Software.
Low-pH Precipitate Method
The atenolol content of the samples was evaluated with
the low-pH precipitate method. In brief, the polyphenolic
hydroxyl containing components were precipitated under
acidic conditions (pH 2) and then dissolved in an alkaline
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solution. Atenolol bound to polyphenolic hydroxyl containing
components can be detected in the solution by HPLC.
A stock solution of atenolol was prepared at a concentration of
10 mg/ml, and a solution of OTP was prepared at a concentration
of 100 mg/ml. Various volumes of OTP were pipetted into 1.5 ml
microcentrifuge tubes (Nest Biotechnology Co., Ltd. China) (0,
10, 20, 50, 100, 200, 400, 600 µl), and 10 µl of atenolol was
added to each tube. Next, 1 M hydrochloric acid was added to
each sample solution to adjust the acidity to pH 2; each sample
was then diluted to 1 ml with deionized water to yield a final
concentration of atenolol 100 µg/ml for each sample. Samples
were vortexed for 2 min and centrifuged at 6 000 g at 25◦C for
30 min. The precipitate and the supernatant were separated. The
precipitate was dissolved in NaOH solution (pH 10). Precipitate
solutions were then diluted with deionized water to 1 ml. The
atenolol content of the supernatant and the precipitate was
determined by HPLC.
Animals and Study Design
Adult SD rats weighing 200–250 g (8 week old) were obtained
from Kunming Medical University (Yunnan, China). The rats
were maintained in controlled conditions (12 h light/12 h dark
cycle, humidity 50–60%; ambient temperature 24 ± 1◦C) and
were provided standard laboratory food (ShooBree R© Rat Food,
Nanjing, China) and water ad libitum. All rat experiments
were performed in the animal facility according to the
institutional guidelines and were approved by the Institutional
Animal Care and Use Committee of the Yunnan Agricultural
University.
After acclimatization for a period of one week, the animals
were divided into two treatment groups consisting of 10 rats
(5 male and 5 female) each: atenolol (50 mg/kg) or OTP
(500 mg/kg) + atenolol (50 mg/kg). Rats were food-deprived for
12 h prior to oral administration.
Plasma and Feces Sample Preparation
Blood samples from the inside canthus were taken at various
intervals (5 min, 10 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h,
12 h, and 24 h) after drug administration. The blood samples
were collected in microcentrifuge tubes with heparin sodium,
centrifuged at 6 000 rpm for 10 min, and the resulting plasma
was kept frozen at −20◦C (DW-40L508, Haier, China) until
analysis.
We collected fecal samples at 2, 4, 6, 8, 12, and 24 h after drug
administration. The fecal samples were frozen at −80◦C (DW-
86L626, Haier, China) and dried in a freezer dryer (FD5-6, Sim
International Group Co.Ltd. China).
Analysis of Atenolol in Plasma and Feces
A 200 µl aliquot of rat plasma from the atenolol group was
pipetted into a 1.5 ml microcentrifuge tube, and then 200 µl of
protein precipitant (6% perchloric acid) was added. After vortex
FIGURE 1 | The content of atenolol by HPLC-FLD analysis. (A) Mobile phase spiked with 31.25 µg/ml of atenolol. (B) Blank plasma spiked with 31.25 µg/ml of
atenolol and 6% Perchloric acid. (C) Blank plasma spiked with 31.25 µg/ml of atenolol and methanol. (D) Blank plasma spiked with 31.25 µg/ml of atenolol and
acetonitrile. (E) Blank plasma spiked with 44.64 µg/ml of atenolol and 10% Trichloroacetic acid. Peaks: 1, precipitant; 2, atenolol.
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mixing for 30 s, the mixture was centrifuged at approximately
3000 g for 15 min. The supernatant solution was transferred
into a disposable 1.5 ml microcentrifuge tube. Next, 20 µl of the
final solution was injected into the HPLC system after filtration
through a 0.45 µm filter unit.
Each rat fecal sample from various time intervals were
weighed by an electronic scale and was transferred into a
50 ml centrifuge tube after trituration; a 50-fold volume of feces
and mobile phase was pipetted for extraction. After ultrasonic
extracting for 1 h, the mixture was centrifuged at approximately
6 000 g for 15 min, the extraction liquid was transferred into
a disposable 1.5 ml microcentrifuge tube, then 20 µl of the
final solution was injected into the HPLC system after filtration
through a 0.45 µm filter membrane.
HPLC-FLD Analysis
Samples were analyzed with an autosampler (G1329B, 1260ALS,
Agilent, USA), a fluorescence detector (G1321B, 1260FLD,
Agilent, USA), an HPLC pump (G1311B, 1260Quat Pump,
Agilent, USA), and a C18 ODS column (ZORBAX SB-C18
4.6 mm*250 mm, 5 microns, Agilent, USA). The analytical
method for atenolol was validated using a mobile phase
consisting of Acetonitrile-50 mM KH2PO4 (6:94, v/v pH 4.0) at
a flow rate of 1 ml/min, and fluorescence detection was set at an
excitation wavelength of 225 nm and an emission wavelength of
300 nm.
Statistical Analysis
All values were presented as the mean ± standard error of
the mean (SEM). Differences within groups were analyzed with
repeated measures one-way ANOVA and two-tailed p < 0.05
was considered to be statistically significant. All analyses were
performed using GraphPad Prism software for Windows (version
5.0 GraphPad Software, Inc., La Jolla, CA, USA).
RESULTS
The Content of Atenolol by HPLC-FLD
Analysis
Atenolol is a widely used cardio-selective beta-blocker.
Quantitative analysis of atenolol in plasma is crucial for the
study of pharmacokinetics and guides rational drug use in
the clinical setting. Rapid, specific, and sensitive methods for
detecting atenolol in plasma are presently available (Kallem et al.,
2013).
When comparing the fluorescence detector (FLD) and the UV
detector (UVD), sensitivity in the former is far better than in the
latter. The resolution of atenolol is affected by several factors; one
of these is the type of mobile phase and its components. In this
study, the mobile phase consisted of acetonitrile-50 mM KH2PO4
(6:94, v/v pH 4.0). The use of acetonitrile in the mobile phase
is to improve peak shape, shorten retention time and enhance
selectivity.
Typical atenolol content in blank plasma samples mixed with
four different types of protein precipitant is shown in Figure 1:
10% trichloroacetic acid group show a low resolution, and
acetonitrile group show a low recovery. To evaluate and compare
the recovery of all protein precipitant, the linearity of the method
was studied for five different concentrations of atenolol. Six
percent perchloric acid was chosen as the precipitating agent to
add to plasma samples for better separating effect and improved
recovery (Table 1). The regression curves for atenolol exhibited
high linearity Y = 11.6∗X+ 2.5298, R2 = 0.9999 (n= 3).
Isothermal Titration Calorimetry Assay
To further identify the interaction of EGCG and atenolol, ITC
was performed to assess the binding of EGCG to atenolol
TABLE 1 | The percentage recovery data of atenolol from human plasma
with four different kinds of protein precipitant.
Protein precipitant Average recovery (%) RSD (%)
10% Trichloroacetic acid 96.73 ± 0.34 0.36
6%Perchloric acid 89.07 ± 0.43 0.48
Acetonitrile 76.06 ± 0.46 0.61
Methanol 69.33 ± 0.70 1.07
Average recovery are means ± SD of five concentration∗100%.
RSD (%) = SD/mean∗100%.
FIGURE 2 | Epigallocatechin-3-O-gallate bind to atenolol in vitro by
isothermal titration calorimetry (ITC) assay. The data indicate that the KD
is 0.419 ± 0.219 mM for interaction between EGCG and atenolol. Top panel,
the titration calorimetry of EGCG with atenolol at room temperature; lower
panel, normalized ITC data for titrations versus molar ratio of EGCG with
atenolol.
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(Figure 2). In this assay, atenolol was titrated with EGCG
at room temperature. The thermodynamics parameters of
interaction between EGCG and atenolol can be calculated by
fitting the raw ITC data. The parameter values were as follows:
N (sites) = 1.42 ± 0.132; 1H = 0.100 ± 0.017 kcal/mol;
1G = −4.61 kcal/mol; −T1S = −4.71 kcal/mol. The
equilibrium dissociation constant (KD) was determined after
analysis of the normalized ITC curve by the MicroCal PEAQ-ITC
Analysis Software. The all data indicated that EGCG can bind to
atenolol with a KD of 0.419± 0.219 mM and a stoichiometry ratio
of 1.42:1.
The Content of Atenolol by the Low-pH
Precipitate Method
Previous research has shown that atenolol can bind to EGCG.
Therefore, in the current study, we set out to observe different
ratios of OTP and atenolol (0:1, 10:1, 20:1, 50:1, 100:1, 200:1,
400:1, 600:1). Precipitation formed in low-pH conditions, and the
precipitate efficiency of OTP in different quantities was observed
(Figure 3A).
A high level of atenolol was tested by HPLC-FLD analysis in
the supernatant of samples containing OTP (Figure 3B). OTP
induced a concentration-dependent decrease in atenolol levels.
At the ratio of 10:1 (OTP: atenolol) and 100:1, OTP significantly
decreased the level of atenolol by 11 and 53% compared to the
ratio of 0:1 (P < 0.01). These results indicated that a strong
positive relationship existed between the dosage of OTP and the
precipitate efficiency of OTP.
To further determine whether the reduced content of atenolol
is combined with OTP and contained in the precipitate, the
precipitate was re-dissolved in pH 10 conditions. A high level of
atenolol was tested in the precipitation solution of the sample
with a mass of OTP (Figure 3C), and the results indicate a
negative relationship between atenolol level and the quantity
of precipitate in the sample. As the oxidative polymerization
product of EGCG, OTP show a strong adsorption with atenolol
to correspond with the ITC test result.
Atenolol Levels of Plasma and Feces
The above results suggest that the atenolol combined with OTP
and the mixture precipitated in the environment of low pH.
To further characterize the combination of atenolol and OTP
in rat gastric juice, atenolol was selected as a control group to
investigate whether the absorption of atenolol was affected by the
presence of OTP.
After administration of atenolol and OTP for various intervals
(5 min, 10 min, 30 min, 1, 2, 4, 6, 8, 12, and 24 h), atenolol levels
in plasma were measured by HPLC to examine the absorption
of atenolol in rats (Figures 4A,B). Atenolol was absorbed
(Tmax: 1.867 h) with the half-life (t1/2) of 6.663 h, However,
FIGURE 3 | The content of atenolol by the low-pH precipitate method. (A) The quantity of precipitation under the condition of pH 2. (B) The level of atenolol of
supernatant under the condition of pH 2. (C) The level of atenolol of re-dissolved solution of precipitation under the condition of pH 10. Data were presented as
mean ± SEM (∗∗P < 0.01; ∗∗∗P < 0.001) and were analyzed with repeated measure (n = 3) one-way ANOVA.
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FIGURE 4 | Atenolol levels of plasma and feces. (A) The atenolol content of plasma at 1 h after ingestion of atenolol group and (B) OTP+atenolol group by
HPLC-FLD analysis. The differences in plasma (C) and fecal (D) level of atenolol at different time point were analyzed with repeated measure (n = 10). Data were
presented as the mean ± SEM (∗∗P < 0.01; ∗∗∗P < 0.001). Peaks: 1, precipitant; 2, atenolol.
compared to the control group (Table 2), AUC0−t (h∗ng/ml),
AUC0−∞(h∗ng/ml), and Cmax of OTP+atenolol group reduced
38.7, 27, and 51%, respectively. plasma atenolol levels were
significantly reduced by OTP after oral administrations 43, 49,
and 55.5% at 30 min, 1 and 2 h, respectively, (P < 0.01)
(Figure 4C). There were no significant differences between the
two groups until 12 h after ingestion, and the atenolol levels
of plasma demonstrated no significant change in the whole
process.
The atenolol levels of plasma in the OTP group were
decreased after ingestion, and we speculated that the absorption
of atenolol was inhibited in rats. To ascertain the cause of
this, feces atenolol levels were examined. The atenolol level in
feces from group OTP+atenolol was higher than in the atenolol
group (Figure 4D). The result indicated that more atenolol
TABLE 2 | Pharmacokinetics parameters.
Parameters Means ± SD
OTP+Atenolol Atenolol
AUC0−t (h∗ng/ml) 15.554 ± 2.665 25.378 ± 2.630
AUC0−∞(h∗ng/ml) 20.996 ± 5.774 28.756 ± 3.803
t1/2 (h) 10.898 ± 5.909 6.663 ± 3.337
Tmax (h) 1.9 ± 2.315 1.867 ± 1.024
Cmax (µg/l) 1.482 ± 0.170 3.03 ± 0.584
was combined with OTP and excreted. In all probability, the
absorption of atenolol was inhibited in rats.
DISCUSSION
Epigallocatechin-3-O-gallate is a vital component of tea, which is
oxidized to form OTP in the process of Pu-er tea fermentation.
ITC assay was performed to assess the binding of EGCG to
atenolol show a certain affinity. OTP contain EGCG as the
major group (Xu et al., 2016), has higher molecular weight
and stronger immune activity, show a stronger affinity with
atenolol (Supplementary Figure S1). One possible mechanism
is that a large number of active EGCG side-chains present
in OTP increase the combining capacity by its affinity. On
the other hand, OTP contains a poly phenolic hydroxyl and
benzene ring of EGCG with a macromolecular dimensional
network structure demonstrating a strong absorbing capacity
with small size substances like atenolol by physisorption. Studies
on the interaction of OTP and atenolol in vitro have illustrated
the ability of OTP to affect the solubility of free atenolol in
water. Free atenolol is reduced in water when OTP is present
under acidic conditions. Another study also found that the ethyl
acetate extract fraction of Pu-er tea has almost no monomeric
polyphenols, theaflavins, or gallic acid (Jie et al., 2006). To
elucidate the mechanism of the OTP-atenolol interaction, we
re-dissolved the precipitation in NaOH solution. The data
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suggested that atenolol was released, and the concentration of
atenolol was positively correlated with the precipitation of OTP,
demonstrating that the changes in interactions due to pH were
reversible.
Atenolol is mainly absorbed by small intestine; one possible
mechanism of the reduced level of atenolol in plasma is a
potential inhibitory effect on the uptake efficiency of the intestine.
Co-administration of atenolol and OTP resulted in the formation
of macromolecular complexes that absorbed atenolol in the
stomach and sedimented in gastric acid. However, free atenolol
cannot separate out under natural conditions. Macromolecular
material is not absorbed by the intestine and then excreted,
explaining the content of atenolol in feces. Other factors may
also be involved. Research suggests that polyphenols inhibit
absorption by regulatory intestinal bacteria (Parkar et al., 2013),
increase the intestinal mucous layer and inhibit the activity
of digestive enzymes and transporters (Schulze et al., 2014;
Guri et al., 2015). Atenolol is a hydrophilic compound, with
a molecular weight of 266.3. This small size would allow
for paracellular absorption and transport through membrane
carriers as well (Lennernas et al., 1994). The transport of
atenolol across the intestinal epithelium may be mediated by
the solute carrier OCT1 (Mimura et al., 2015). OTP may
decrease the absorption of atenolol by regulating the expression
of drug receptor, but the present study could not confirm this
conjecture.
Because of the health benefits of tea, a lot of research more
inclined to the positive role of tea, such as combine with anti-
cancer drug to promote efficacy and reduce the side effects (Singh
et al., 2015; Zaletok et al., 2015). A trend has been observed
in recent years: the users and researchers concerning the active
effect of food supplements on the health, but the food-drug
interactions can result in adverse effects in bioavailability and
pharmacokinetics (Margina˘ et al., 2015). Many anti-nutritional
compounds in complementary food result in malabsorption
(Roos et al., 2013). Edible products also require long-term care.
Tea was considered to reduce the drug effects in ancient Chinese
saying, mainly because of polyphenol structure are known to
chelate metal ions and inhibit the utilization (Kim et al., 2011;
Andrews et al., 2014), and exhibit a high affinity with protein
via hydrogen bonding and hydrophobic effects (García-Conesa,
2015).
In present study, our finding suggest that OTP from Pu-er tea
may reduce the absorption of atenolol in rats by the reason of
OTP possessing absorption property, as for the other reaction is
not clearly, further experiments should be perform to confirm the
findings.
CONCLUSION
In conclusion, our results showed that OTP combined with
atenolol to become a precipitate in a low-pH environment, and
OTP influenced the absorption of atenolol in rats, which may also
occur in humans.
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